Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy

Issa Asfour1, Shahid Karim2,3, Sair A Tabraiz2

  • 1East Tennessee State University, Johnson City, Tennessee, USA.

Insights

Late gadolinium enhancement (LGE) in hypertrophic cardiomyopathy (HCM) is linked to T-wave inversion on ECG but not precordial voltage. LGE did not increase atrial fibrillation risk in this adult study.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Late gadolinium enhancement (LGE) via cardiovascular magnetic resonance (CMR) identifies myocardial fibrosis in hypertrophic cardiomyopathy (HCM).
  • The relationship between LGE, electrocardiogram (ECG) abnormalities, and atrial fibrillation (AF) risk in adult HCM patients is not fully understood.

Purpose of the Study:

  • To examine the association between LGE presence and extent with ECG characteristics.
  • To assess the link between LGE and the incidence of AF in adults with HCM.

Main Methods:

  • Retrospective cohort study of 144 adult HCM patients.
  • CMR and 12-lead ECG data collected within 30 days.
  • LGE quantified as % LV mass; categorized as absent, <5%, or ≥5%.
  • ECG parameters analyzed, including QRS voltage and repolarization abnormalities.
  • Median follow-up of 6.6 years for incident AF assessment.

Main Results:

  • LGE present in 67% of patients; 22% had ≥5% LGE.
  • No significant difference in precordial voltage across LGE groups.
  • T-wave inversion more frequent in leads I, aVL, and V4 in patients with LGE.
  • Patients with ≥5% LGE showed significantly lower LVEF.
  • LGE presence was not associated with increased AF risk (HR 1.8, 95% CI 0.6-5.3).

Conclusions:

  • In adult HCM, LGE correlates with specific ECG repolarization abnormalities, notably T-wave inversion in lateral leads.
  • LGE does not significantly impact precordial voltage in adult HCM patients.
  • Findings contrast with pediatric HCM, highlighting age-specific associations.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...